<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2021.743305</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Ursolic Acid Targets Glucosyltransferase and Inhibits Its Activity to Prevent <italic>Streptococcus mutans</italic> Biofilm Formation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Yucui</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
<xref rid="fn4" ref-type="author-notes"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/473342/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yanxin</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="fn4" ref-type="author-notes"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Cong</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff4" ref-type="aff"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chi</surname>
<given-names>Zhongmei</given-names>
</name>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bai</surname>
<given-names>Miao</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sun</surname>
<given-names>Luguo</given-names>
</name>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/423863/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Li</given-names>
</name>
<xref rid="aff5" ref-type="aff"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Chunlei</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Zhenbo</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiaoguang</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1412041/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Jingwen</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="aff3" ref-type="aff"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Shuyue</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Lei</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1121950/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Guannan</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zheng</surname>
<given-names>Lihua</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c002" ref-type="corresp"><sup>&#x002A;</sup></xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>State Key Laboratory of Microbial Technology, Shandong University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>NMPA Key Laboratory for Quality Control of Cell and Gene Therapy Medicine Products, Northeast Normal University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<aff id="aff4"><sup>4</sup><institution>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Medical Research Center, Sun Yat-Sen Memorial Hospital</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country></aff>
<aff id="aff5"><sup>5</sup><institution>Faculty of Chemistry, Northeast Normal University</institution>, <addr-line>Changchun</addr-line>, <country>China</country></aff>
<author-notes>
<fn id="fn1" fn-type="edited-by"><p>Edited by: Prescilla Emy Nagao, Rio de Janeiro State University, Brazil</p></fn>
<fn id="fn2" fn-type="edited-by"><p>Reviewed by: Geelsu Hwang, University of Pennsylvania, United States; Latifa Bousarghin, University of Rennes 1, France</p></fn>
<corresp id="c001">&#x002A;Correspondence: Luguo Sun, <email>sunluguo01@163.com</email></corresp>
<corresp id="c002">Lihua Zheng, <email>zhenglh015@nenu.edu.cn</email></corresp>
<fn id="fn4" fn-type="equal"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn id="fn3" fn-type="other"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>743305</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>08</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2021 Liu, Huang, Fan, Chi, Bai, Sun, Yang, Yu, Song, Yang, Yi, Wang, Liu, Wang and Zheng.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Liu, Huang, Fan, Chi, Bai, Sun, Yang, Yu, Song, Yang, Yi, Wang, Liu, Wang and Zheng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p><italic>Streptococcus mutans (S. mutans)</italic>, the prime pathogen of dental caries, can secrete glucosyltransferases (GTFs) to synthesize extracellular polysaccharides (EPSs), which are the virulence determinants of cariogenic biofilms. Ursolic acid, a type of pentacyclic triterpene natural compound, has shown potential antibiofilm effects on <italic>S. mutans</italic>. To investigate the mechanisms of ursolic acid-mediated inhibition of <italic>S. mutans</italic> biofilm formation, we first demonstrated that ursolic acid could decrease the viability and structural integrity of biofilms, as evidenced by XTT, crystal violet, and live/dead staining assays. Then, we further revealed that ursolic acid could compete with the inherent substrate to occupy the catalytic center of GTFs to inhibit EPS formation, and this was confirmed by GTF activity assays, computer simulations, site-directed mutagenesis, and capillary electrophoresis (CE). In conclusion, ursolic acid can decrease bacterial viability and prevent <italic>S. mutans</italic> biofilm formation by binding and inhibiting the activity of GTFs.</p>
</abstract>
<kwd-group>
<kwd>ursolic acid</kwd>
<kwd>biofilms</kwd>
<kwd>extracellular polysaccharides</kwd>
<kwd>glucosyltransferases</kwd>
<kwd>mechanism</kwd>
</kwd-group>
<contract-num rid="cn1">81700709</contract-num>
<contract-num rid="cn2">135130006</contract-num>
<contract-num rid="cn2">130029804</contract-num>
<contract-num rid="cn2">111498001</contract-num>
<contract-num rid="cn2">131004006</contract-num>
<contract-num rid="cn3">20200602023ZP</contract-num>
<contract-num rid="cn3">20200901002SF</contract-num>
<contract-num rid="cn3">20200404124YY</contract-num>
<contract-num rid="cn4">2020C015</contract-num>
<contract-num rid="cn5">JJKH20201177KJ</contract-num>
<contract-num rid="cn6">2020009</contract-num>
<contract-sponsor id="cn1">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn2">Fundamental Research Funds for the Central Universities<named-content content-type="fundref-id">10.13039/501100012226</named-content>
</contract-sponsor>
<contract-sponsor id="cn3">Research Foundation of Jilin Provincial Science and Technology Development</contract-sponsor>
<contract-sponsor id="cn4">Foundation of Jilin Province Development and Reform Commission</contract-sponsor>
<contract-sponsor id="cn5">Education Department of Jilin Province<named-content content-type="fundref-id">10.13039/501100010211</named-content>
</contract-sponsor>
<contract-sponsor id="cn6">Foundation of Human Resources and Social Security Department of Jilin Province</contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="47"/>
<page-count count="9"/>
<word-count count="6955"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<title>Introduction</title>
<p>Most oral diseases, including periodontal diseases and especially dental caries, are prevalent and common public health problems worldwide (<xref ref-type="bibr" rid="ref19">Jakubovics et al., 2021</xref>). Approximately 60&#x2013;90% of school-aged children and almost all adults suffer from dental caries (<xref ref-type="bibr" rid="ref44">Wong et al., 2017</xref>). Dental caries is a chronic bacterial infectious disease that occurs on the tooth surface (<xref ref-type="bibr" rid="ref40">Taubman and Nash, 2006</xref>). Traditional methods used to prevent or cure dental caries include mechanical removal of plaque (e.g., toothbrushing), the usage of broad-spectrum antibiotics, and more comprehensive forms of clinical treatment (e.g., root canal therapy, surgery, and dental restorations; <xref ref-type="bibr" rid="ref8">Chen et al., 2016</xref>). However, the effect of prevention can be limited by poor toothbrushing technique and drug resistance (<xref ref-type="bibr" rid="ref11">Cummins, 2013</xref>). Dental treatment is expensive, averaging 5% of total health expenditures and 20% of out-of-pocket health expenditures in most high-income countries, and is beyond the capacity of healthcare systems in most low- and middle-income countries (<xref ref-type="bibr" rid="ref41">Vernazza et al., 2021</xref>). Therefore, more effective preventive and therapeutic strategies for dental caries are needed.</p>
<p>Dental caries is a typical biofilm induction-related disease, and cariogenic biofilms are one of the main factors leading to bacterial infection since they can protect microorganisms by enhancing microbial resistance to the host&#x2019;s immunologic defense and antibacterial agents (<xref ref-type="bibr" rid="ref38">Takahashi and Nyvad, 2011</xref>; <xref ref-type="bibr" rid="ref33">Pitts et al., 2017</xref>). <italic>Streptococcus mutans (S. mutans)</italic>, the prime pathogen of dental caries, is an important contributor to the formation of cariogenic biofilms (<xref ref-type="bibr" rid="ref42">Wang et al., 2020</xref>). <italic>S. mutans</italic> secretes three types of glucosyltransferases (GTFs), namely, GTF-I (also known as GtfB), GTF-SI (GtfC), and GTF-S (GtfD; <xref ref-type="bibr" rid="ref5">Bowen and Koo, 2011</xref>). These GTFs can use dietary sucrose to synthesize extracellular polysaccharides (EPSs), and EPSs are the virulence determinants of cariogenic biofilms (<xref ref-type="bibr" rid="ref39">Tamesada et al., 2004</xref>; <xref ref-type="bibr" rid="ref5">Bowen and Koo, 2011</xref>; <xref ref-type="bibr" rid="ref20">Ja&#x00F1;a et al., 2018</xref>). GTF-I and GTF-SI catalyze mainly the synthesis of water-insoluble glucans, and GTF-S produces mainly water-soluble glucans (<xref ref-type="bibr" rid="ref28">Monchois et al., 1999</xref>; <xref ref-type="bibr" rid="ref4">Bowen et al., 2018</xref>). Water-insoluble glucans help bacteria adhering and aggregating on the tooth surface to form biofilms, while water-soluble glucan may supply a source of metabolizable carbohydrates for plaque bacteria and induce water-insoluble glucan formation (<xref ref-type="bibr" rid="ref19">Jakubovics et al., 2021</xref>). Therefore, GTFs play key roles in causing and forming dental caries and are an effective target for the prevention and treatment of dental caries or other related diseases (e.g., infective endocarditis; <xref ref-type="bibr" rid="ref36">Shun et al., 2005</xref>).</p>
<p>Ursolic acid, a type of pentacyclic triterpene compound, can be isolated in abundance from many foods (e.g., apples, olive, and basil) and medicinal plants (e.g., <italic>Malus pumila</italic>, <italic>Ocimum basiliacum</italic>, and <italic>Rosmarinus officinalis</italic>; <xref ref-type="bibr" rid="ref17">Ikeda et al., 2008</xref>; <xref ref-type="bibr" rid="ref3">Bacanl&#x0131; et al., 2017</xref>; <xref ref-type="bibr" rid="ref15">Hui et al., 2021</xref>). Ursolic acids have been reported to have many beneficial bioactivities, such as anticancer (<xref ref-type="bibr" rid="ref32">Patlolla and Rao, 2012</xref>), anti-inflammatory (<xref ref-type="bibr" rid="ref30">P&#x00E1;dua et al., 2014</xref>), antimicrobial (<xref ref-type="bibr" rid="ref21">Kim et al., 2012</xref>), immunity regulation (<xref ref-type="bibr" rid="ref46">Xu et al., 2019</xref>), and antiviral activities (<xref ref-type="bibr" rid="ref22">Kong et al., 2013</xref>). In our previous research, we confirmed that the crude extract of <italic>Bergenia crassifolia</italic> leaves could inhibit <italic>S. mutans</italic> biofilm formation (<xref ref-type="bibr" rid="ref26">Liu et al., 2017</xref>). In a screen of the active ingredients of <italic>Bergenia crassifolia</italic> leaves for antibiofilm activity, we found that ursolic acid had a significant effect. Here, we confirmed the antibiofilm activities of ursolic acid against <italic>S. mutans</italic> and further revealed the mechanism underlying the inhibitory effect of ursolic acid on GTF-mediated synthesis of EPSs. Our study provides a potential antimicrobial agent that can be used to prevent and cure oral and other GTF-related diseases.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec3">
<title>Bacterial Strain, Growth Conditions, and Chemicals</title>
<p><italic>S. mutans</italic> (ATCC 251175) was obtained from the Guangdong Microbiology Culture Center and was cultured in brain heart infusion (BHI) broth (Hopebio, Qingdao, China) supplemented with 1% sucrose at 37&#x00B0;C for 24h under aerobic conditions. After incubation, the bacterial concentration was 10<sup>7</sup>cfu/ml, as determined by spectrophotometry (OD<sub>630</sub>=0.2). Ursolic acid was purchased from the National Institutes for Food and Drug Control with purity &#x003E;98% and was dissolved in dimethyl sulfoxide.</p>
</sec>
<sec id="sec4">
<title>Antimicrobial Activity Assay</title>
<p>The potential inhibitory activity of ursolic acid against <italic>S. mutans</italic> was determined by the microdilution method as described previously (<xref ref-type="bibr" rid="ref26">Liu et al., 2017</xref>), with minor modifications. Briefly, ursolic acid was serially diluted twofold in BHI broth containing 1% sucrose, with the final concentration of ursolic acid ranging from 0.25 to 0.031mg/ml. Twenty microliters of sterile solution of resazurin sodium per well was added to the bacterial culture and incubated at 37&#x00B0;C for 24h. BHI broth alone was used as blank control, bacterial suspension alone was used as a noninhibition negative control, and chlorhexidine treatment at a final concentration of 0.6mg/ml was used as a positive control. As bacteria grow, resazurin is reduced to resorufin, resulting in the medium color changing from blue to pink (<xref ref-type="bibr" rid="ref31">Palomino et al., 2002</xref>; <xref ref-type="bibr" rid="ref35">Sarker et al., 2007</xref>). The lowest concentration of ursolic acid that could inhibit the medium color change from blue to pink was defined as the minimal inhibitory concentration (<xref ref-type="bibr" rid="ref31">Palomino et al., 2002</xref>; <xref ref-type="bibr" rid="ref37">S&#x00FC;ntar et al., 2016</xref>). The bacterial cultures treated with ursolic acid at concentrations equal to or higher than the minimum inhibitory concentration (MIC) were transferred to BHI agar plates and incubated at 37&#x00B0;C for 24h. The lowest concentration that resulted in no visible bacterial colonies on the agar plates after incubation was defined as the minimal bactericidal concentration (MBC; <xref ref-type="bibr" rid="ref26">Liu et al., 2017</xref>).</p>
</sec>
<sec id="sec5">
<title>XTT Reduction Assay</title>
<p>The effect of ursolic acid on the viability of biofilms was evaluated using a 2,3-bis (2-methyloxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduction assay as described previously (<xref ref-type="bibr" rid="ref13">Duque et al., 2017</xref>), with some modification. Briefly, after 24h of incubation for cultured bacteria to form biofilms in 96-well microplates, supernatants were removed, and the wells were gently washed three times with PBS (pH 7.0) to remove nonadhered bacteria. Then, the cultures were incubated at 37&#x00B0;C for another 22h in 200&#x03BC;l of BHI broth including 100&#x03BC;l of ursolic acid at various concentrations. After removing the supernatants, 50&#x03BC;l of XTT (Sigma, St. Louis, MO, United States) reagent was added, and the microplate was kept in the dark for 2h at 37&#x00B0;C. Then, the absorbance of the colored product was detected at 490nm using an ELISA reader. Alternatively, after ursolic acid treatment, a crystal violet assay was used to evaluate the attachment of biofilm biomass as described previously (<xref ref-type="bibr" rid="ref6">Cardoso S&#x00E1; et al., 2012</xref>).</p>
</sec>
<sec id="sec6">
<title>Live/Dead Bacterial Staining</title>
<p>Fluorescence staining was used to determine biofilm integrity as described previously (<xref ref-type="bibr" rid="ref26">Liu et al., 2017</xref>). After biofilm formation, ursolic acid was added at a final concentration of 1/2 MIC followed by incubation at 37&#x00B0;C for another 18h. The culture was then removed from the supernatant and gently washed twice with sterile water. Staining was carried out by means of the Live/Dead BacLight Bacterial Viability Kit (L13152, Invitrogen, Carlsbad, CA, United States) for 30min at room temperature in the dark. Stained cells were observed under a fluorescence microscope (Nikon Eclipse 80i; Nikon Co., Japan). The kit utilizes a mixture of SYTO 9, a green-fluorescent nucleic acid stains and propidium iodide (PI), a red-fluorescent nucleic acid stains. SYTO 9 is a membrane-permeable fluorescent marker that stains all cells, while PI penetrates only bacteria with damaged membranes and stains dead cells red. Twenty fields per sample were randomly selected to analyze the intensity of red and green fluorescence.</p>
</sec>
<sec id="sec7">
<title>Extracellular Polysaccharide Production Assay</title>
<p>The method for quantification of EPS production was conducted as described previously (<xref ref-type="bibr" rid="ref29">Packiavathy et al., 2012</xref>). Briefly, the bacterial culture was incubated with or without ursolic acid at concentrations ranging from 0.008 to 0.125mg/ml at 37&#x00B0;C for 16h, the culture was centrifuged (4&#x00B0;C, 12000&#x00D7;<italic>g</italic>, 30min), and the supernatants and cells were collected. The water-soluble and water-insoluble glucans were prepared using the method described previously (<xref ref-type="bibr" rid="ref001">Yano et al., 2012</xref>). Briefly, water-soluble glucans were obtained by ethanol precipitation of the supernatants. The cells were resuspended in 1M NaOH and centrifuged to collect supernatants, which were used to prepare water-insoluble glucans by ethanol precipitation. The phenol/H<sub>2</sub>SO<sub>4</sub> method was used to quantify two types of EPS in the supernatant as described previously (<xref ref-type="bibr" rid="ref26">Liu et al., 2017</xref>). The absorbance of the color was detected at 490nm using an ELISA reader.</p>
</sec>
<sec id="sec8">
<title>Molecular Dynamics Simulations</title>
<p>The crystal structure of glucansucrase was downloaded from the Protein Data Bank (ID: 3AIC) as the receptor, and the preparation work was done using the software Gold 5.2 and AutoDockTool 1.5.6. The MD simulation of the system was performed for 20ns under the npt ensemble, and the data were saved every other 5ps. CPPTRAJ was used for data analysis. The MMPBSA.py module was used to compute the binding free energy between the protein and ligand.</p>
<p>To further confirm the binding site between GTF-SI and ursolic acid, the amino acids in the predicted binding site were replaced by other amino acids, as shown in <xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref> Afterward, the mutant GTF-SI proteins were subjected to molecular docking under the same conditions as above.</p>
</sec>
<sec id="sec9">
<title>GTF Activity Assay</title>
<p>The method for analyzing the enzymatic activity of the crude extract of GTFs was used as described previously by Koo <italic>et al</italic> (<xref ref-type="bibr" rid="ref23">Koo et al., 2000</xref>). A 20-mL bacterial suspension of <italic>S. mutans</italic> was incubated in 200ml of BHI broth containing 1% sucrose at 37&#x00B0;C. After incubation, supernatants were collected, and ammonium sulfate was added at 60% saturation for 24h to prepare the protein. The crude enzymes were dissolved in PBS (pH 6.0). The reaction system mixture was the same as that described previously (<xref ref-type="bibr" rid="ref26">Liu et al., 2017</xref>). The final concentration of ursolic acid ranging from 0.04 to 0.12mg/ml was used to measure the inhibition of the synthesis of EPSs. After incubation, the method to determine the amount of the two types of glucans was applied as described above.</p>
</sec>
<sec id="sec10">
<title>Preparation of Recombinant GTF and Its Mutants</title>
<p>cDNA fragments of wild-type GTF-SI (GenBank: M22054.1) and two mutant GTF-SI variants (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S1</xref>) were synthesized and inserted into the <italic>Nde</italic>I and <italic>Xho</italic>I sites of pCold I to generate pCold-GTF-SI recombinant plasmids with a 6&#x00D7; histidine tag at the N-terminus of the proteins (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). The recombinant proteins were purified by using GE metal affinity resin and dialyzed. SDS-PAGE was used to analyze recombinant GTF-SI proteins (shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S1</xref>).</p>
</sec>
<sec id="sec11">
<title>Capillary Electrophoresis Assay</title>
<p>Capillary electrophoresis (CE) was used to quantify fructose production catalyzed by GTFs as described previously (<xref ref-type="bibr" rid="ref34">Rizelio et al., 2012</xref>). Recombinant GTF-SI was crudely extracted from recombinant transformants by ultrasonic disruption. Then, 50&#x03BC;l of the crude enzyme solution together with or without ursolic acid at a final concentration of 0.03mg/ml or 0.02mg/ml was added to 1ml of sucrose (0.1M) and incubated at 37&#x00B0;C for 2h. After incubation, the culture was centrifuged (4&#x00B0;C, 12000&#x00D7;<italic>g</italic>, 10min), and the supernatants were collected and filtered with a 0.22-&#x03BC;m nylon membrane before being subjected to the CE assay. The CE assay was conducted in a CE system, and the conditions to detect fructose were as follows: The detection wavelength was set at 254nm; the temperature was maintained at 25&#x00B0;C; and fused silica capillaries had dimensions of 50cm in total length and 40cm in effective length, and the inner diameter and outer diameter were 50&#x03BC;m and 375&#x03BC;m, respectively. The sample injection was maintained at an elevation difference of 20cm from the nearest detector for 5s, and the separation voltage was 25kV. The capillary system was rinsed with 0.1M NaOH for 5min, distilled water for 3min, and PBS for 3min before each run.</p>
<p>CE can also be used to detect the binding of drugs and proteins, which was used in this study to analyze the interaction of ursolic acid with GTF-SI and its variants as described previously (<xref ref-type="bibr" rid="ref24">Liang et al., 2020</xref>). GTF-SI and its variants were dissolved in PBS (20mm, pH=6.8) and filtered with a 0.22-&#x03BC;m nylon membrane. Ursolic acid was dissolved in the same solution as that used to dissolve the proteins, and the final concentration was 0.3mg/ml. Afterward, the GTF or its variants were incubated with ursolic acid for 2h. Finally, CE was conducted as described above with a few differences: The detection wavelength was 210nm, and the separation voltage was 20kV.</p>
</sec>
</sec>
<sec id="sec12" sec-type="results">
<title>Results</title>
<sec id="sec13">
<title>Effects of Ursolic Acid on Biofilms</title>
<p>Biofilms are the key factors in the induction of dental caries and periodontitis. We first measured the MIC and the MBC values of ursolic acid against <italic>S. mutans</italic>. The MIC value is the lowest concentration that could prevent the culture color from changing blue to pink. The MBC value is the lowest concentration that resulted in no visible bacterial colonies on the agar plates after incubation. As shown in <xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S2</xref> and shown in <xref rid="tab1" ref-type="table">Table 1</xref>, both the MIC and MBC values of ursolic acid against <italic>S. mutans</italic> were 0.25mg/ml. Based on the concentration of antimicrobial activities, we evaluated the effect of ursolic acid on <italic>S. mutans</italic> biofilms by the XTT reduction method. As shown in <xref rid="fig1" ref-type="fig">Figure 1A</xref>, the bacterial viability within the biofilms decreased as the concentration of ursolic acid increased, while the difference was most significant at the concentration of 0.063mg/ml. Compared with the positive control, ursolic acid showed similar inhibitory effects on the bacterial viability of biofilms at 0.125mg/ml (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>). In addition, the crystal violet staining results showed that the amount of biofilm was decreased upon ursolic acid treatment, as shown in <xref rid="fig1" ref-type="fig">Figure 1B</xref>, which is consistent with the data of the XTT reduction assay.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption><p>The MIC and MBC values of ursolic acid against <italic>S. mutans</italic>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle" rowspan="3">Compound</th>
<th align="center" valign="top" colspan="2">Species/Strain</th>
</tr>
<tr>
<th align="center" valign="top" colspan="2"><italic>S. mutans</italic> (ATCC 25175)</th>
</tr>
<tr>
<th align="center" valign="top">MIC (mg/mL)</th>
<th align="center" valign="top">MBC (mg/mL)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Ursolic acid</td>
<td align="center" valign="top"><bold>0.25</bold></td>
<td align="center" valign="top"><bold>0.25</bold></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Negative control: the bacterial suspension alone</italic>;</p>
<p><italic>Positive control: chlorhexidine at a final concentration of 0.6mg/ml</italic>.</p>
</table-wrap-foot>
</table-wrap>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption><p>Effects of ursolic acid on biofilms. <bold>(A)</bold>: Percentage of bacterial viability within biofilms detected by XTT assay; <bold>(B)</bold>: Inhibitory percentage of ursolic acid on biofilm formation detected by crystal violet staining. Data are presented as the mean&#x00B1;standard deviation. <sup>&#x002A;</sup><italic>p</italic>&#x003C;0.05 and <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x003C;0.01. <bold>(C)</bold>: Effects of ursolic acid on biofilm structure. SYTO 9: green fluorescence, which stains both the dead and live bacterial cells; PI: red fluorescence, which stains dead bacterial cells. Control: ursolic acid untreated biofilms; CH: chlorhexidine (the positive control).</p></caption>
<graphic xlink:href="fmicb-12-743305-g001.tif"/>
</fig>
<p>To observe the direct effects of ursolic acid on biofilms, the Live/Dead BacLight Bacterial Viability kit was used to examine <italic>S. mutans</italic> bacteria within the biofilm, as shown in <xref rid="fig1" ref-type="fig">Figure 1</xref>. Compared with the control sample, the sample treated with ursolic acid had a large number of red-stained bacterial cells, indicating dead cells. Furthermore, the biofilms were thin. This result confirmed that ursolic acid could significantly destroy biofilms by affecting bacterial survival and adhesion.</p>
</sec>
<sec id="sec14">
<title>Effects of Ursolic Acid on GTF Activity</title>
<p>EPSs are the key factors contributing to bacterial colonization, biofilm formation, maturation, and caries. Because EPSs are synthesized by GTFs, we explored the effect of ursolic acid on GTF activity in crude bacterial extracts in the presence of sucrose <italic>in vitro</italic>. As shown in <xref rid="fig2" ref-type="fig">Figure 2</xref>, ursolic acid inhibited the activity of GTFs, resulting in a decrease in the synthesis of EPS products. The inhibition of ursolic acid on water-soluble glucan production was stronger than that on water-insoluble glucan production at low concentrations of less than 0.06mg/ml, while this inhibition tendency was reversed at concentrations from 0.06mg/ml to 0.12mg/ml. Combined with the data above, these results suggest that ursolic acid could suppress the aggregation or adhesion of <italic>S. mutans</italic> to form cariogenic biofilms by preventing GTFs from synthesizing EPSs.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption><p>Effect of ursolic acid on glucosyltransferase (GTF) activities. GTFs were crudely extracted from bacterial culture medium and were then used to test the effect of ursolic acid on its activities by using an <italic>in vitro</italic> enzymatic reaction system. The final concentration of ursolic acid ranged from 0.04 to 0.12mg/ml. Extracellular polysaccharides (EPSs), including soluble and insoluble glucans, which are the catalytic products of GTFs, were measured as indicators of GTF activity. The data are presented as the mean &#x00B1; standard deviation.</p></caption>
<graphic xlink:href="fmicb-12-743305-g002.tif"/>
</fig>
</sec>
<sec id="sec15">
<title>The Mode of Interaction Between Ursolic Acid and GTF-SI</title>
<p>The catalytic center of GTF-SI has been shown to include two subsites for EPS synthesis: Subsite+1 contains the key amino acids for sucrose to bind, and subsite-1 contains the key amino acids for glucosyl moiety polymerization to form EPSs (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). In particular, Trp517 provides a platform for the acceptor glycosyl moiety of sucrose, and Tyr430 participates in hydrophobic interactions with carbon atoms of the glycosyl moiety in subsite+1; however, Asp909 and Tyr916 are related to recognition of the glucosyl moiety of the primary sucrose and formation of the glycosyl-enzyme intermediate in subsite-1 (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). As shown in <xref rid="fig3" ref-type="fig">Figure 3A</xref>, the simulation data showed that ursolic acid formed hydrogen bonds with Tyr430 and Asp909 of GTF-SI and had hydrophobic interactions with Leu433, Leu434, Phe907, Trp517, and Tyr916, which are the key sites for catalyzing sucrose to synthesize EPSs. Furthermore, the MD simulation results showed that the binding free energy of GTF-SI to ursolic acid was similar to that of sucrose (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S2</xref>). Then, we made two mutant GTF-SI variants in which the predicted amino acids that are essential for ursolic acid binding were replaced with other amino acids (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S2</xref>) to further verify the binding indicated by the simulation. The simulation showed that the number of amino acids in either GTF-SI variant that formed hydrogen bonds and hydrophobic interactions with ursolic acid decreased compared with that in wild-type GTF-SI (<xref rid="fig3" ref-type="fig">Figures 3B</xref>,<xref rid="fig3" ref-type="fig">C</xref>), and the interaction and binding free energy of the GTF-SI variants with ursolic acid were also decreased (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S2</xref>, <xref ref-type="supplementary-material" rid="SM2">S3</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption><p>Interaction between ursolic acid and GTF-SI. <bold>(A-C)</bold> Binding model of ursolic acid with GTF-SI and its variants simulated by Gold software. (A) Wild-type GTF-SI; (B) GTF-SI variant A; (C) GTF-SI variant B. Ursolic acid, as the ligand, is shown in green. The protein is shown as a cartoon with pink color. The yellow dotted lines represent hydrogen bonds. <bold>(D-F)</bold>: Interaction between ursolic acid and GTF-SI measured by CE assay. The black line represents the migration time of GTF-SI and its variants, whereas the red line is the migration time of GTF-SI or its variants together with ursolic acid. (D) Wild-type GTF-SI; (E) GTF-SI variant A; (F) GTF-SI variant B. Arrows point to the peak of the protein (black)/protein and ursolic acid complex (red).</p></caption>
<graphic xlink:href="fmicb-12-743305-g003.tif"/>
</fig>
<p>Then, CE technology was used to further determine the interaction between GTFs and ursolic acid <italic>in vitro</italic>. As shown in <xref rid="fig3" ref-type="fig">Figure 3D</xref>, compared with that of the control, the migration time of the protein was prolonged by the addition of ursolic acid, which indicated that ursolic acid could bind with GTF-SI to change the charge-mass ratio, leading to a migration time-shift. The CE results further showed that the retention time of the variant A or variant B proteins was shorter than that of wild-type GTF-SI after the addition of ursolic acid, suggesting that the interaction between GTF-SI and ursolic acid became weaker or even lost as several key amino acids at the binding site were replaced (<xref rid="fig3" ref-type="fig">Figures 3E</xref>,<xref rid="fig3" ref-type="fig">F</xref>). These results indicate that ursolic acid might inhibit the enzymatic activity of GTFs through direct binding and that Phe907, Asp909 and Tyr916 in GTF-SI might be the key amino acids responsible for ursolic acid binding.</p>
</sec>
<sec id="sec16">
<title>Effects of Ursolic Acid on EPSs and Fructose Production</title>
<p>The process of GTF synthesis of EPS includes two steps: First, the GTF enzyme binds with sucrose, and then, EPS synthesis is catalyzed. After sucrose binds with subsite+1 of the GTF, the glucosyl group of sucrose dissociates from subsite+1 and then binds subsite-1 of the GTF to form an intermediate that catalyzes EPS production, while the fructosyl group of sucrose dissociates from subsite+1 of the GTF to produce the by-product, namely, fructose (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). Therefore, the production of fructose and EPSs would decrease when the binding site and catalytic site of the GTF are occupied by a molecule other than sucrose. Since the amino acids in GTF-SI that are essential for ursolic acid binding are also indispensable for sucrose recognition and since the MD simulation results showed that the binding free energy of GTF-SI to ursolic acid was similar to that of sucrose (<xref ref-type="supplementary-material" rid="SM2">Supplementary Table S2</xref>), we hypothesized that ursolic acid may suppress GTF activity by competitively blocking sucrose binding. To test this hypothesis, we evaluated the effects of ursolic acid on the production of EPS and fructose. To confirm the effect of ursolic acid on EPS synthesis by <italic>S. mutans</italic>, water-soluble glucans and water-insoluble glucans were obtained from bacterial culture treated with or without ursolic acid for 16h, and the phenol/H<sub>2</sub>SO<sub>4</sub> method was used to detect the content of both types of EPSs. As shown in <xref rid="fig4" ref-type="fig">Figure 4A</xref>, ursolic acid at concentrations of 0.008mg/ml to 0.125mg/ml inhibited the production of both water-soluble and water-insoluble glucans. Additionally, the amount of fructose produced by crude recombinant GTF-SI was further measured in the presence of sucrose and ursolic acid for 2h. As shown in <xref rid="fig4" ref-type="fig">Figure 4B</xref>, the amount of fructose production decreased with the addition of ursolic acid to the enzymatic reaction system, and the effect of a high concentration was more obvious than that of a low concentration. Based on this in combination with the data above, we proposed that ursolic acid could compete with sucrose to occupy the catalytic center of the GTF, which then inhibits the enzymes that synthesize EPSs and eventually prevents bacterial adhesion to form biofilms.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption><p>Effect of ursolic acid on GTF catalyzed products. <bold>(A)</bold> Inhibitory percentage of ursolic acid on EPS production determined by phenol/H<sub>2</sub>SO<sub>4</sub> analysis. After incubation with ursolic acid for 16h, the water-soluble glucans and water-insoluble glucans were prepared from bacterial culture using the method described above. Phenol/H<sub>2</sub>SO<sub>4</sub> analysis was used to quantify the two types of EPSs. Data are presented as the mean &#x00B1; standard deviation; <bold>(B)</bold> Effect of ursolic acid on fructose production by GTFs determined <italic>via</italic> CE assay. Data are presented as the mean &#x00B1; standard deviation. <sup>&#x002A;</sup><italic>p</italic>&#x003C;0.05 and <sup>&#x002A;&#x002A;</sup><italic>p</italic>&#x003C;0.01.</p></caption>
<graphic xlink:href="fmicb-12-743305-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="sec17" sec-type="discussions">
<title>Discussion</title>
<p>Dental plaque is an oral bacterial biofilm that plays a key role in oral diseases (<xref ref-type="bibr" rid="ref1">Adler et al., 2013</xref>). Biofilm formation enhances bacterial tolerance to drugs or the environment; thus, inhibition of biofilm formation and damage to the biofilm are the effective ways to prevent or cure oral diseases (<xref ref-type="bibr" rid="ref10">Chenicheri et al., 2017</xref>). <italic>S. mutans</italic> is the principal bacterium that forms biofilms by adhesion to teeth and is considered the most important pathogen for dental caries. In the present study, we investigated the effects of ursolic acid on the growth and cariogenicity of biofilms formed by <italic>S. mutans</italic>. The results indicated that ursolic acid could effectively prevent biofilm formation of <italic>S. mutans</italic> through two pathways: (i) Ursolic acid decreased the viability of planktonic and sessile bacteria; and (ii) ursolic acid inhibited GTF-mediated synthesis of EPSs by competing with sucrose to occupy the catalytic center of the enzyme, which decreased bacterial adhesion and biofilm formation. Therefore, ursolic acid has great potential to be developed as an oral protective or therapeutic drug for oral disease.</p>
<p>Dental caries is a secondary bacterial disease that affects the health and quality of life of half of the world&#x2019;s population (<xref ref-type="bibr" rid="ref16">Hwang et al., 2014</xref>). Attention is needed to develop effective prevention and treatment methods. The results of this study indicated that ursolic acid inhibits planktonic <italic>S. mutans</italic>. Previously, it was reported that ursolic acid could have an inhibitory effect on other cariogenic pathogens, such as <italic>Streptococcus sobrius</italic> (<xref ref-type="bibr" rid="ref12">do Nascimento et al., 2014</xref>). Therefore, ursolic acid may have significant antimicrobial activity against pathogenic bacteria involved in dental caries. Traditionally, fluoride, a common component of oral care products, is used to support oral hygiene and health. However, some studies have found that excess fluoride is unsafe for children and adults, as it may induce color nonuniformity of teeth and loss of potency (<xref ref-type="bibr" rid="ref43">Wong et al., 2010</xref>). Chlorhexidine, a broad-spectrum antibiotic, is widely used to prevent or cure oral diseases (<xref ref-type="bibr" rid="ref7">Charugundla et al., 2015</xref>). It was reported that <italic>S. mutans</italic> has some drug resistance against chlorhexidine (<xref ref-type="bibr" rid="ref27">L&#x00F3;pez-Jornet et al., 2012</xref>). Therefore, it is necessary to develop new effective components to decrease the drug resistance of oral pathogens. Interestingly, ursolic acid showed inhibitory activity on biofilms at 1/2 MIC, similar to chlorhexidine (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure S3</xref>). Moreover, ursolic acid has low toxicity and is versatile in terms of its biological activity, evidenced by its antiviral, liver protective, and whitening effects (<xref ref-type="bibr" rid="ref47">Zou et al., 2019</xref>; <xref ref-type="bibr" rid="ref25">Liu et al., 2021</xref>). Therefore, ursolic acid has great potential to be used as a lead compound in the development of an effective inhibitor for dental caries and as a protective agent for oral health.</p>
<p>Biofilm formation is a dynamic process that includes adhesion, aggregation, and maturation (<xref ref-type="bibr" rid="ref2">Arciola et al., 2012</xref>). GTFs can synthesize EPSs by using sucrose as a substrate, which provides an adherent ability for bacterial colonization to promote biofilm formation and development (<xref ref-type="bibr" rid="ref14">Hellmuth et al., 2008</xref>; <xref ref-type="bibr" rid="ref9">Chen et al., 2013</xref>). Therefore, GTFs are key pathogenic factors in the induction of dental caries. It has been reported that subsite-1 and subsite+1 are the main partial catalytic centers of GTF-SI for sucrose binding and EPS formation (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). The primary bound sucrose is attacked by a proton to induce hydrolysis, and then, the glucosyl group binds to subsite-1 of GTF as an intermediate, while fructose is released from subsite+1 of the enzyme (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). Amino acid residues such as Arg475, Asp477, Glu515, Asp588, and Tyr916 construct subsite-1 of GTF for catalyzing glucan formation, while the amino acid residues located at subsite+1, such as Tyr430, Leu433, and Trp517, constitute the critical domains for recognition of the moiety (<xref ref-type="bibr" rid="ref18">Ito et al., 2011</xref>). The molecular docking analysis showed that ursolic acid is sandwiched by Tyr430 and Asp909 to occupy the catalytic center and that the 3-hydroxyl group of ursolic acid points toward the active center. The experimental results confirmed that ursolic acid could bind with GTFs and that the binding ability disappeared as the action site was replaced by other amino acids. Quantitative analysis of EPSs and fructose showed that ursolic acid could decrease the levels of EPSs and fructose. These results confirm that ursolic acid competes with sucrose to occupy the catalytic center of GTFs, which may lead to the failure of GTFs to use sucrose as a substrate to synthesize EPSs (as shown in <xref rid="fig2" ref-type="fig">Figures 2</xref>, <xref rid="fig4" ref-type="fig">4</xref>). In addition, the recognition of the glucosyl moiety of primary sucrose by GTFs and the intermediate formation at subsite-1 are well conserved in other <italic>Streptococcus</italic> species related to dental caries and infective endocarditis, such as <italic>Streptococcus gordonii</italic> (<xref ref-type="bibr" rid="ref14">Hellmuth et al., 2008</xref>). Therefore, ursolic acid could be developed as an antimicrobial agent for dental caries or <italic>Streptococcus</italic>-related diseases.</p>
</sec>
<sec id="sec18" sec-type="conclusions">
<title>Conclusion</title>
<p>We characterized the mechanism of <italic>S. mutans</italic> biofilm formation inhibition by ursolic acid. More importantly, ursolic acid can bind to GTFs instead of sucrose to interfere with microbial adhesion and aggregation through interactions with seven amino acids (Tyr430, Asp909, Leu433, Leu434, Phe907, Trp517, and Tyr916) of the enzyme, which is necessary for biofilm formation and even destroys mature biofilms, to prevent and cure dental caries and other oral diseases. Thus, ursolic acid has the potential to be developed as a drug or oral cleaning product to protect against and cure oral disease and other GTF-related diseases in the clinic. Finally, Leu433, Leu434, and Phe907 may serve as new target sites to screen inhibitors of GTFs to develop new antimicrobials.</p>
</sec>
<sec id="sec19" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The data sets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref rid="sec22" ref-type="sec">Supplementary Material</xref>.</p>
</sec>
<sec id="sec20">
<title>Author Contributions</title>
<p>LY, BM, FC, and CZ performed the experiments. LY and SL designed the study, carried out the analysis and interpretation, and drafted and revised the manuscript. HY, YL, and ZL designed the study and analyzed the data. YC, SZ, YX, YJ, WS, LL, and WG assisted with the data analysis. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="sec41" sec-type="funding-information">
<title>Funding</title>
<p>This study was supported by grants from the following foundations: the National Natural Science Foundation of China (no. 81700709), the Fundamental Research Funds for the Central Universities (nos. 135130006, 130029804, 111498001, and 131004006), the Research Foundation of Jilin Provincial Science and Technology Development (nos. 20200602023ZP, 20200901002SF, and 20200404124YY), the Foundation of Jilin Province Development and Reform Commission (no. 2020C015), the funds of the Education Department of Jilin Province (no. JJKH20201177KJ), and the Foundation of Human Resources and Social Security Department of Jilin Province (no. 2020009).</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec001" sec-type="disclaimer">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<ack>
<p>This article is dedicated to my advisor Yuxin Li, who passed away last year, and commemorates his guidance in my life.</p>
</ack>
<sec id="sec22" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at:</p>
<p><ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2021.743305/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2021.743305/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Table_1.DOC" id="SM2" mimetype="application/msword" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adler</surname> <given-names>C. J.</given-names></name> <name><surname>Dobney</surname> <given-names>K.</given-names></name> <name><surname>Weyrich</surname> <given-names>L. S.</given-names></name> <name><surname>Kaidonis</surname> <given-names>J.</given-names></name> <name><surname>Walker</surname> <given-names>A. W.</given-names></name> <name><surname>Haak</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and industrial revolutions</article-title>. <source>Nat. Genet.</source> <volume>45</volume>, <fpage>450</fpage>&#x2013;<lpage>455</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ng.2536</pub-id>, PMID: <pub-id pub-id-type="pmid">23416520</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arciola</surname> <given-names>C. R.</given-names></name> <name><surname>Campoccia</surname> <given-names>D.</given-names></name> <name><surname>Speziale</surname> <given-names>P.</given-names></name> <name><surname>Montanaro</surname> <given-names>L.</given-names></name> <name><surname>Costerton</surname> <given-names>J. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Biofilm formation in <italic>staphylococcus</italic> implant infections. a review of molecular mechanisms and implications for biofilm-resistant materials</article-title>. <source>Biomaterials</source> <volume>33</volume>, <fpage>5967</fpage>&#x2013;<lpage>5982</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biomaterials.2012.05.031</pub-id>, PMID: <pub-id pub-id-type="pmid">22695065</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bacanl&#x0131;</surname> <given-names>M.</given-names></name> <name><surname>Ba&#x015F;aran</surname> <given-names>A. A.</given-names></name> <name><surname>Ba&#x015F;aran</surname> <given-names>N.</given-names></name></person-group> (<year>2017</year>). <article-title>The antioxidant, cytotoxic, and antigenotoxic effects of galangin, puerarin, and ursolic acid in mammalian cells</article-title>. <source>Drug Chem. Toxicol.</source> <volume>40</volume>, <fpage>256</fpage>&#x2013;<lpage>262</lpage>. doi: <pub-id pub-id-type="doi">10.1080/01480545.2016.1209680</pub-id>, PMID: <pub-id pub-id-type="pmid">27461151</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname> <given-names>W. H.</given-names></name> <name><surname>Burne</surname> <given-names>R. A.</given-names></name> <name><surname>Wu</surname> <given-names>H.</given-names></name> <name><surname>Koo</surname> <given-names>H.</given-names></name></person-group> (<year>2018</year>). <article-title>Oral biofilms: pathogens, matrix, and Polymicrobial interactions in microenvironments</article-title>. <source>Trends. Microbiol.</source> <volume>26</volume>, <fpage>229</fpage>&#x2013;<lpage>242</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tim.2017.09.008</pub-id>, PMID: <pub-id pub-id-type="pmid">29097091</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname> <given-names>W. H.</given-names></name> <name><surname>Koo</surname> <given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Biology of Streptococcus mutans-derived glucosyltransferases: role in extracellular matrix formation of cariogenic biofilms</article-title>. <source>Caries Res.</source> <volume>5</volume>, <fpage>69</fpage>&#x2013;<lpage>86</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000324598</pub-id>, PMID: <pub-id pub-id-type="pmid">21346355</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cardoso S&#x00E1;</surname> <given-names>N.</given-names></name> <name><surname>Cavalcante</surname> <given-names>T. T.</given-names></name> <name><surname>Ara&#x00FA;jo</surname> <given-names>A. X.</given-names></name> <name><surname>dos Santos</surname> <given-names>H. S.</given-names></name> <name><surname>Albuquerque</surname> <given-names>M. R.</given-names></name> <name><surname>Bandeira</surname> <given-names>P. N.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>Antimicrobial and antibiofilm action of Casbane Diterpene from <italic>croton nepetaefolius</italic> against oral bacteria</article-title>. <source>Arch. Oral Biol.</source> <volume>57</volume>, <fpage>550</fpage>&#x2013;<lpage>555</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.archoralbio.2011.10.016</pub-id>, PMID: <pub-id pub-id-type="pmid">22119044</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Charugundla</surname> <given-names>B. R.</given-names></name> <name><surname>Anjum</surname> <given-names>S.</given-names></name> <name><surname>Mocherla</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Comparative effect of fluoride, essential oil and chlorhexidine mouth rinses on dental plaque and gingivitis in patients with and without dental caries: a randomized controlled trial</article-title>. <source>Int. J. Dent. Hyg.</source> <volume>13</volume>, <fpage>104</fpage>&#x2013;<lpage>109</lpage>. doi: <pub-id pub-id-type="doi">10.1111/idh.12094</pub-id>, PMID: <pub-id pub-id-type="pmid">25040544</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Ren</surname> <given-names>Z.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Zeng</surname> <given-names>J.</given-names></name> <name><surname>Zou</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Inhibition of <italic>Streptococcus mutans</italic> biofilm formation, extracellular polysaccharide production, and virulence by an oxazole derivative</article-title>. <source>App. Microbial. cell. physiol.</source> <volume>100</volume>, <fpage>857</fpage>&#x2013;<lpage>867</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00253-015-7092-1</pub-id>, PMID: <pub-id pub-id-type="pmid">26526453</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y. P.</given-names></name> <name><surname>Zhang</surname> <given-names>P.</given-names></name> <name><surname>Guo</surname> <given-names>J. S.</given-names></name> <name><surname>Fang</surname> <given-names>F.</given-names></name> <name><surname>Gao</surname> <given-names>X.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Functional groups characteristics of EPS in biofilm growing on different carriers</article-title>. <source>Chemosphere</source> <volume>92</volume>, <fpage>633</fpage>&#x2013;<lpage>638</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chemosphere.2013.01.059</pub-id>, PMID: <pub-id pub-id-type="pmid">23466089</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chenicheri</surname> <given-names>S.</given-names></name> <name><surname>R</surname> <given-names>U.</given-names></name> <name><surname>Ramachandran</surname> <given-names>R.</given-names></name> <name><surname>Thomas</surname> <given-names>V.</given-names></name> <name><surname>Wood</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Insight into Oral biofilm: primary, secondary and residual caries and Phyto-challenged solutions</article-title>. <source>Open Dent. J.</source> <volume>11</volume>, <fpage>312</fpage>&#x2013;<lpage>333</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1874210601711010312</pub-id>, PMID: <pub-id pub-id-type="pmid">28839480</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cummins</surname> <given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Dental caries: a disease which remains a public health concern in the 21st century&#x2013;the exploration of a breakthrough technology for caries prevention</article-title>. <source>J. Clin. Pediatr. Dentisitry.</source> <volume>24</volume>, <fpage>A1</fpage>&#x2013;<lpage>A14</lpage>. PMID: <pub-id pub-id-type="pmid">24156135</pub-id>.</citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>do Nascimento</surname> <given-names>P. G.</given-names></name> <name><surname>Lemos</surname> <given-names>T. L.</given-names></name> <name><surname>Bizerra</surname> <given-names>A. M.</given-names></name> <name><surname>Arriaga</surname> <given-names>&#x00C2;. M.</given-names></name> <name><surname>Ferreira</surname> <given-names>D. A.</given-names></name> <name><surname>Santiago</surname></name> <etal/></person-group> (<year>2014</year>). <article-title>Antibacterial and antioxidant activities of ursolic acid and derivatives</article-title>. <source>Molecules</source> <volume>19</volume>, <fpage>1317</fpage>&#x2013;<lpage>1327</lpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules19011317</pub-id>, PMID: <pub-id pub-id-type="pmid">24451251</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duque</surname> <given-names>C.</given-names></name> <name><surname>Aida</surname> <given-names>K. L.</given-names></name> <name><surname>Pereira</surname> <given-names>J. A.</given-names></name> <name><surname>Teixeira</surname> <given-names>G. S.</given-names></name> <name><surname>Caldo-Teixeira</surname> <given-names>A. S.</given-names></name> <name><surname>Perrone</surname> <given-names>L. R.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>I<italic>n vitro</italic> and <italic>in vivo</italic> evaluations of glass-ionomer cement containing chlorhexidine for atraumatic restorative treatment</article-title>. <source>J. Appl. Oral Sci.</source> <volume>25</volume>, <fpage>541</fpage>&#x2013;<lpage>550</lpage>. doi: <pub-id pub-id-type="doi">10.1590/1678-7757-2016-0195</pub-id>, PMID: <pub-id pub-id-type="pmid">29069152</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hellmuth</surname> <given-names>H.</given-names></name> <name><surname>Wittrock</surname> <given-names>S.</given-names></name> <name><surname>Kralj</surname> <given-names>S.</given-names></name> <name><surname>Dijkhuizen</surname> <given-names>L.</given-names></name> <name><surname>Hofer</surname> <given-names>B.</given-names></name> <name><surname>Seibel</surname> <given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Engineering the glucan-sucrase GTFR enzyme reaction and glycosidic bond specificity: toward tailor-made polymer and oligosaccharide products</article-title>. <source>Biochemistry</source> <volume>47</volume>, <fpage>6678</fpage>&#x2013;<lpage>6684</lpage>. doi: <pub-id pub-id-type="doi">10.1021/bi800563r</pub-id>, PMID: <pub-id pub-id-type="pmid">18512955</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname> <given-names>Y.</given-names></name> <name><surname>Wen</surname> <given-names>S.</given-names></name> <name><surname>Lihong</surname> <given-names>W.</given-names></name> <name><surname>Chuang</surname> <given-names>W.</given-names></name> <name><surname>Chaoyun</surname> <given-names>W.</given-names></name></person-group> (<year>2021</year>). <article-title>Molecular structures of nonvolatile components in the Haihong fruit wine and their free radical scavenging effect</article-title>. <source>Food Chem.</source> <volume>15</volume>:<fpage>129298</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodchem.2021.129298</pub-id>, PMID: <pub-id pub-id-type="pmid">33711703</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>G.</given-names></name> <name><surname>Klein</surname> <given-names>M. I.</given-names></name> <name><surname>Koo</surname> <given-names>H.</given-names></name></person-group> (<year>2014</year>). <article-title>Analysis of the mechanical stability and surface detachment of mature <italic>Streptococcus mutans</italic> biofilms by applying a rage of external shear forces</article-title>. <source>Biofouling</source> <volume>30</volume>, <fpage>1079</fpage>&#x2013;<lpage>1091</lpage>. doi: <pub-id pub-id-type="doi">10.1080/08927014.2014.969249</pub-id>, PMID: <pub-id pub-id-type="pmid">25355611</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname> <given-names>Y.</given-names></name> <name><surname>Murakami</surname> <given-names>A.</given-names></name> <name><surname>Ohigashi</surname> <given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Ursolic acid: an anti-and pro-inflammatory triterpenoid</article-title>. <source>Mol. Nutr. Food Res.</source> <volume>52</volume>, <fpage>26</fpage>&#x2013;<lpage>42</lpage>. doi: <pub-id pub-id-type="doi">10.1002/mnfr.200700389</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname> <given-names>K.</given-names></name> <name><surname>Ito</surname> <given-names>S.</given-names></name> <name><surname>Shimamura</surname> <given-names>T.</given-names></name> <name><surname>Weyand</surname> <given-names>S.</given-names></name> <name><surname>Kawarasaki</surname> <given-names>Y.</given-names></name> <name><surname>Misaka</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Crystal structure of Glucansucrase from the dental caries pathogen <italic>Streptococcus mutans</italic></article-title>. <source>J. Mol. Biol.</source> <volume>408</volume>, <fpage>177</fpage>&#x2013;<lpage>186</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jmb.2011.02.028</pub-id>, PMID: <pub-id pub-id-type="pmid">21354427</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jakubovics</surname> <given-names>N. S.</given-names></name> <name><surname>Goodman</surname> <given-names>S. D.</given-names></name> <name><surname>Mashburn-Warren</surname> <given-names>L.</given-names></name> <name><surname>Stafford</surname> <given-names>G. P.</given-names></name> <name><surname>Cieplik</surname> <given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>The dental plaque biofilm matrix</article-title>. <source>Periodontol.</source> <volume>86</volume>, <fpage>32</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1111/prd.12361</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ja&#x00F1;a</surname> <given-names>G. A.</given-names></name> <name><surname>Mendoza</surname> <given-names>F.</given-names></name> <name><surname>Osorio</surname> <given-names>M. I.</given-names></name> <name><surname>Alderete</surname> <given-names>J. B.</given-names></name> <name><surname>Fernandes</surname> <given-names>P. A.</given-names></name> <name><surname>Ramos</surname> <given-names>M. J.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>A QM/MM approach on the structural and stereoelectronic factors governing glycosylation by GTF-SI from <italic>Streptococcus mutans</italic></article-title>. <source>Org. Biomol. Chem.</source> <volume>16</volume>, <fpage>2438</fpage>&#x2013;<lpage>2447</lpage>. doi: <pub-id pub-id-type="doi">10.1039/C8OB00284C</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>S. G.</given-names></name> <name><surname>Min</surname> <given-names>J. K.</given-names></name> <name><surname>Jin</surname> <given-names>D.</given-names></name> <name><surname>Park</surname> <given-names>S. N.</given-names></name> <name><surname>Kook</surname> <given-names>J. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Antimicrobial effect of ursolic acid and oleanolic acid against methicillin-resistant <italic>Staphylococcus aureus</italic></article-title>. <source>J. Microbiol.</source> <volume>48</volume>, <fpage>212</fpage>&#x2013;<lpage>215</lpage>. doi: <pub-id pub-id-type="doi">10.7845/kjm.2012.029</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>L.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Liao</surname> <given-names>Q.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Sun</surname> <given-names>R.</given-names></name> <name><surname>Zhu</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity</article-title>. <source>Antivir. Res.</source> <volume>98</volume>, <fpage>44</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.02.003</pub-id>, PMID: <pub-id pub-id-type="pmid">23422646</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname> <given-names>H.</given-names></name> <name><surname>Gomes</surname> <given-names>B. P.</given-names></name> <name><surname>Rosalen</surname> <given-names>P. L.</given-names></name> <name><surname>Ambrosano</surname> <given-names>G. M.</given-names></name> <name><surname>Park</surname> <given-names>Y. K.</given-names></name> <name><surname>Cury</surname> <given-names>J. A.</given-names></name></person-group> (<year>2000</year>). <article-title><italic>In vitro</italic> antimicrobial activity of propolis and <italic>Arnica Montana</italic> against oral pathogens</article-title>. <source>Arch. Oral Biol.</source> <volume>45</volume>, <fpage>141</fpage>&#x2013;<lpage>148</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0003-9969(99)00117-X</pub-id>, PMID: <pub-id pub-id-type="pmid">10716618</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>C.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <name><surname>Bai</surname> <given-names>M.</given-names></name> <name><surname>Huang</surname> <given-names>Y.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source>Pharmacol. Res.</source> <volume>153</volume>:<fpage>104657</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.phrs.2020.104657</pub-id>, PMID: <pub-id pub-id-type="pmid">31982488</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>H. R.</given-names></name> <name><surname>Ahmad</surname> <given-names>N.</given-names></name> <name><surname>Lv</surname> <given-names>B.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name></person-group> (<year>2021</year>). <article-title>Advances in production and structural derivatization of the promising molecule ursolic acid</article-title>. <source>Biotechnol. J.</source> <volume>6</volume>:<fpage>e2000657</fpage>. doi: <pub-id pub-id-type="doi">10.1002/biot.202000657</pub-id>, PMID: <pub-id pub-id-type="pmid">34096160</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Xu</surname> <given-names>Y.</given-names></name> <name><surname>Song</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>F.</given-names></name> <name><surname>Sun</surname> <given-names>L.</given-names></name> <name><surname>Liu</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Anti-biofilm activities from <italic>Bergenia crassifolia</italic> leaves against <italic>Streptococcus mutans</italic></article-title>. <source>Front. Microbiol.</source> <volume>8</volume>:<fpage>1738</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmicb.2017.01738</pub-id>, PMID: <pub-id pub-id-type="pmid">28955316</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x00F3;pez-Jornet</surname> <given-names>P.</given-names></name> <name><surname>Plana-Ramon</surname> <given-names>E.</given-names></name> <name><surname>Leston</surname> <given-names>J. S.</given-names></name> <name><surname>Pons-Fuster</surname> <given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Short-term side effects of 0.2% alcohol-free chlorhexidine mouthrinse in geriatric patients: a randomized, double-blind, placebo-controlled study</article-title>. <source>Gerodontology</source> <volume>29</volume>, <fpage>292</fpage>&#x2013;<lpage>298</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1741-2358.2012.00671.x</pub-id>, PMID: <pub-id pub-id-type="pmid">22486193</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monchois</surname> <given-names>V.</given-names></name> <name><surname>Willemot</surname> <given-names>R. M.</given-names></name> <name><surname>Monsan</surname> <given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Glucansucrases: mechanism of action and structure&#x2013;function relationships</article-title>. <source>FEMS. Microbiol. Rev.</source> <volume>23</volume>, <fpage>131</fpage>&#x2013;<lpage>151</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0168-6445(98)00041-2</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Packiavathy</surname> <given-names>I. A. S. V.</given-names></name> <name><surname>Agilandeswari</surname> <given-names>P.</given-names></name> <name><surname>Musthafa</surname> <given-names>K. S.</given-names></name> <name><surname>Pandian</surname> <given-names>S. K.</given-names></name> <name><surname>Ravi</surname> <given-names>A. V.</given-names></name></person-group> (<year>2012</year>). <article-title>Antibiofilm and quorum sensing inhibitory potential of <italic>Cuminum cyminum</italic> and its secondary metabolite methyl eugenol against gram negative bacterial pathogens</article-title>. <source>Food Res. Int.</source> <volume>45</volume>, <fpage>141</fpage>&#x2013;<lpage>148</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.foodres.2011.10.022</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>P&#x00E1;dua</surname> <given-names>T. A.</given-names></name> <name><surname>de Abreu</surname> <given-names>B. S.</given-names></name> <name><surname>Costa</surname> <given-names>T. E.</given-names></name> <name><surname>Nakamura</surname> <given-names>M. J.</given-names></name> <name><surname>Valente</surname> <given-names>L. M.</given-names></name> <name><surname>Henriques</surname> <given-names>M. d.</given-names></name> <etal/></person-group> (<year>2014</year>). <article-title>Anti-inflammatory effects of methyl ursolate obtained from a chemically derived crude extract of apple peels: potential use in rheumatoid arthritis.</article-title> <source>Arch. Pharm. Res.</source> <volume>37</volume>, <fpage>1487</fpage>&#x2013;<lpage>1495</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12272-014-0345-1</pub-id>, PMID: <pub-id pub-id-type="pmid">24733672</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palomino</surname> <given-names>J. C.</given-names></name> <name><surname>Martin</surname> <given-names>A.</given-names></name> <name><surname>Camacho</surname> <given-names>M.</given-names></name> <name><surname>Guerra</surname> <given-names>H.</given-names></name> <name><surname>Swings</surname> <given-names>J.</given-names></name> <name><surname>Portaels</surname> <given-names>F.</given-names></name></person-group> (<year>2002</year>). <article-title>Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in mycobacterium tuberculosis</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>46</volume>, <fpage>2720</fpage>&#x2013;<lpage>2722</lpage>. doi: <pub-id pub-id-type="doi">10.1128/AAC.46.8.2720-2722.2002</pub-id>, PMID: <pub-id pub-id-type="pmid">12121966</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patlolla</surname> <given-names>J. M.</given-names></name> <name><surname>Rao</surname> <given-names>C. V.</given-names></name></person-group> (<year>2012</year>). <article-title>Triterpenoids for cancer prevention and treatment: current status and future prospects</article-title>. <source>Curr. Pharm. Biotechnol.</source> <volume>13</volume>, <fpage>147</fpage>&#x2013;<lpage>155</lpage>. doi: <pub-id pub-id-type="doi">10.2174/138920112798868719</pub-id>, PMID: <pub-id pub-id-type="pmid">21466427</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pitts</surname> <given-names>N. B.</given-names></name> <name><surname>Zero</surname> <given-names>D. T.</given-names></name> <name><surname>Marsh</surname> <given-names>P. D.</given-names></name> <name><surname>Ekstrand</surname> <given-names>K.</given-names></name> <name><surname>Weintraub</surname> <given-names>J. A.</given-names></name> <name><surname>Ramos-Gomez</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Dental caries</article-title>. <source>Nature Review Disease Primers</source> <volume>3</volume>:<fpage>17030</fpage>. doi: <pub-id pub-id-type="doi">10.1038/nrdp.2017.30</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rizelio</surname> <given-names>V. M.</given-names></name> <name><surname>Tenfen</surname> <given-names>L.</given-names></name> <name><surname>da Silveira</surname> <given-names>R.</given-names></name> <name><surname>Gonzaga</surname> <given-names>L. V.</given-names></name> <name><surname>Costa</surname> <given-names>A. C.</given-names></name> <name><surname>Fett</surname> <given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Development of a fast capillary electrophoresis method for determination of carbohydrates in honey samples</article-title>. <source>Talanta</source> <volume>93</volume>, <fpage>62</fpage>&#x2013;<lpage>66</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.talanta.2012.01.034</pub-id>, PMID: <pub-id pub-id-type="pmid">22483877</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarker</surname> <given-names>S. D.</given-names></name> <name><surname>Nahar</surname> <given-names>L.</given-names></name> <name><surname>Kumarasamy</surname> <given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals</article-title>. <source>Methods</source> <volume>42</volume>, <fpage>321</fpage>&#x2013;<lpage>324</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ymeth.2007.01.006</pub-id>, PMID: <pub-id pub-id-type="pmid">17560319</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shun</surname> <given-names>C. T.</given-names></name> <name><surname>Lu</surname> <given-names>S. Y.</given-names></name> <name><surname>Yeh</surname> <given-names>C. Y.</given-names></name> <name><surname>Chiang</surname> <given-names>C. P.</given-names></name> <name><surname>Chia</surname> <given-names>J. S.</given-names></name> <name><surname>Chen</surname> <given-names>J. Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Glucosyltransferases of viridans streptococci are modulins of interleukin-6 induction in infective endocarditis</article-title>. <source>Infect. Immunnity.</source> <volume>73</volume>, <fpage>3261</fpage>&#x2013;<lpage>3270</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.73.6.3261-3270.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15908350</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>S&#x00FC;ntar</surname> <given-names>I.</given-names></name> <name><surname>Oyard&#x0131;</surname> <given-names>O.</given-names></name> <name><surname>Akkol</surname> <given-names>E. K.</given-names></name> <name><surname>Oz&#x00E7;elik</surname> <given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Antimicrobial effect of the extracts from <italic>Hypericum perforatum</italic> against oral bacteria and biofilm formation</article-title>. <source>Pharm. Biol.</source> <volume>54</volume>, <fpage>1065</fpage>&#x2013;<lpage>1070</lpage>. doi: <pub-id pub-id-type="doi">10.3109/13880209.2015.1102948</pub-id>, PMID: <pub-id pub-id-type="pmid">26510970</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname> <given-names>N.</given-names></name> <name><surname>Nyvad</surname> <given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>The role of bacteria in the caries process: ecological perspectives</article-title>. <source>J. Dent. Res.</source> <volume>90</volume>, <fpage>294</fpage>&#x2013;<lpage>303</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0022034510379602</pub-id>, PMID: <pub-id pub-id-type="pmid">20924061</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tamesada</surname> <given-names>M.</given-names></name> <name><surname>Kawabata</surname> <given-names>S.</given-names></name> <name><surname>Fujiwara</surname> <given-names>T.</given-names></name> <name><surname>Hamada</surname> <given-names>S.</given-names></name></person-group> (<year>2004</year>). <article-title>Synergistic effects of streptococcal glucosyl-transferases on adhesive biofilm formation</article-title>. <source>J. Dent. Res.</source> <volume>83</volume>, <fpage>874</fpage>&#x2013;<lpage>879</lpage>. doi: <pub-id pub-id-type="doi">10.1177/154405910408301110</pub-id>, PMID: <pub-id pub-id-type="pmid">15505239</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taubman</surname> <given-names>M. A.</given-names></name> <name><surname>Nash</surname> <given-names>D. A.</given-names></name></person-group> (<year>2006</year>). <article-title>The scientific and public-health imperative for a vaccine against dental caries</article-title>. <source>Nat. Rev. Immunol.</source> <volume>6</volume>, <fpage>555</fpage>&#x2013;<lpage>563</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri1857</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vernazza</surname> <given-names>C. R.</given-names></name> <name><surname>Birch</surname> <given-names>S.</given-names></name> <name><surname>Pitts</surname> <given-names>N. B.</given-names></name></person-group> (<year>2021</year>). <article-title>Reorienting Oral health services to prevention: economic perspectives</article-title>. <source>J. Dent. Res.</source> <volume>100</volume>, <fpage>576</fpage>&#x2013;<lpage>582</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0022034520986794</pub-id>, PMID: <pub-id pub-id-type="pmid">33478327</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>C.</given-names></name> <name><surname>van der Mei</surname> <given-names>H. C.</given-names></name> <name><surname>Busscher</surname> <given-names>H. J.</given-names></name> <name><surname>Ren</surname> <given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title><italic>Streptococcus mutans</italic> adhesion force sensing in multi-species oral biofilms</article-title>. <source>npj. Biofilms. Microbiomes.</source> <volume>6</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41522-020-0135-0</pub-id>, PMID: <pub-id pub-id-type="pmid">32581220</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>M. C.</given-names></name> <name><surname>Glenny</surname> <given-names>A. M.</given-names></name> <name><surname>Tsang</surname> <given-names>B. W.</given-names></name> <name><surname>Lo</surname> <given-names>E. C.</given-names></name> <name><surname>Worthington</surname> <given-names>H. V.</given-names></name> <name><surname>Marinho</surname> <given-names>V. C.</given-names></name></person-group> (<year>2010</year>). <article-title>Topical fluoride as a cause of dental fluorosis in children</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>1</volume>:<fpage>CD007693</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41522-020-0135-0</pub-id>, PMID: <pub-id pub-id-type="pmid">20091645</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname> <given-names>A.</given-names></name> <name><surname>Subar</surname> <given-names>P. E.</given-names></name> <name><surname>Young</surname> <given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Dental caries: an update on dental trends and therapy</article-title>. <source>Adv. Pediatics.</source> <volume>64</volume>, <fpage>307</fpage>&#x2013;<lpage>330</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.yapd.2017.03.011</pub-id>, PMID: <pub-id pub-id-type="pmid">28688595</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>H.</given-names></name> <name><surname>Zhang</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>X. L.</given-names></name> <name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Yue</surname> <given-names>L. T.</given-names></name> <name><surname>Zhang</surname> <given-names>X. X.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways</article-title>. <source>J. Neuroimmunol.</source> <volume>330</volume>, <fpage>181</fpage>&#x2013;<lpage>183</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jneuroim.2019.03.016</pub-id>, PMID: <pub-id pub-id-type="pmid">30929679</pub-id></citation></ref>
<ref id="ref001"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname> <given-names>A.</given-names></name> <name><surname>Kikuchi</surname> <given-names>S.</given-names></name> <name><surname>Takahashi</surname> <given-names>T.</given-names></name> <name><surname>Kohama</surname> <given-names>K.</given-names></name> <name><surname>Yoshida</surname> <given-names>Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Inhibitory effects of the phenolic fraction from the pomace of Vitis coignetiae on biofilm formation by Streptococcus mutans</article-title>. <source>Arch. Oral Biol.</source> <volume>57</volume>, <fpage>711</fpage>&#x2013;<lpage>719</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.archoralbio.2012.01.001</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>J.</given-names></name> <name><surname>Lin</surname> <given-names>J.</given-names></name> <name><surname>Li</surname> <given-names>C.</given-names></name> <name><surname>Zhao</surname> <given-names>R.</given-names></name> <name><surname>Fan</surname> <given-names>L.</given-names></name> <name><surname>Yu</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Ursolic acid in cancer treatment and metastatic chemoprevention: from synthesized derivatives to Nanoformulations in preclinical studies</article-title>. <source>Curr. Cancer Drug Targets</source> <volume>19</volume>, <fpage>245</fpage>&#x2013;<lpage>256</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1568009618666181016145940</pub-id>, PMID: <pub-id pub-id-type="pmid">30332961</pub-id></citation></ref>
</ref-list>
</back>
</article>